Frierson Hf
Impact in
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
- Oncology top 10%
- Cancer-related Molecular Pathways
- Viral-associated cancers and disorders
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 3
- Cancer Diagnosis and Treatment 2
-
- Gastrointestinal Tumor Research and Treatment 2
- Co-authors
- Gaffey MjCraig A. RumpelQ TianDouglas W. FranquemontChristopher A. MoskalukWeiss LmMills SeThomas Löning
- Journals
- Oncogene (2 papers)The Journal of Pathology (1 paper)PubMed (15 papers)
- Partner nations
- United StatesSwedenBelgium
In The Last Decade
Frierson Hf
18 papers receiving 649 citations
Peers
Comparison fields: 5 of 48
- Gastroenterology 152
- Oncology 319
- Pathology and Forensic Medicine 183
- Dermatology 83
- Pulmonary and Respiratory Medicine 153
Countries citing papers authored by Frierson Hf
This map shows the geographic impact of Frierson Hf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frierson Hf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frierson Hf more than expected).
Fields of papers citing papers by Frierson Hf
This network shows the impact of papers produced by Frierson Hf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frierson Hf. The network helps show where Frierson Hf may publish in the future.
Co-authors
The 25 scholars most cited alongside Frierson Hf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 74 | |
| 2 | 2006 | 107 | |
| 3 | 1999 | 144 | |
| 4 | Coexpression of parathyroid hormone-related protein and its receptor in breast carcinoma: a potential autocrine effector system. | 1998 | 21 |
| 5 | Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma. | 1996 | 27 |
| 6 | Immunohistochemical staining and Southern blot hybridization for glutathione S-transferase pi in mammary infiltrating ductal carcinoma. | 1995 | 4 |
| 7 | Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study. | 1995 | 47 |
| 8 | Proliferating cell nuclear antigen immunoreactivity and prognosis of gastrointestinal stromal tumors. | 1995 | 32 |
| 9 | Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis. | 1995 | 33 |
| 10 | Cytokeratin in anaplastic large cell lymphoma. | 1994 | 24 |
| 11 | Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations. | 1993 | 20 |
| 12 | Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance. | 1993 | 58 |
| 13 | Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables. | 1993 | 6 |
| 14 | c-erbB-2 (HER-2/neu) oncopeptide immunoreactivity in localized, high-grade transitional cell carcinoma of the bladder. | 1992 | 11 |
| 15 | Pathologic quiz case 2. Clear cell carcinoma, consistent with metastatic renal cell carcinoma. | 1988 | 20 |
| 16 | T-immunoblastic lymphoma mimicking B-immunoblastic lymphoma. | 1987 | 9 |
| 17 | Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease. | 1985 | 24 |
| 18 | Osteosarcoma of the mandible. | 1984 | 2 |
About Frierson Hf
Frierson Hf is a scholar working on Oncology, Gastroenterology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Nephrology, having authored 18 papers that have together received 663 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Breast Lesions and Carcinomas (2 papers), Cancer Diagnosis and Treatment (2 papers), Breast Cancer Treatment Studies (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Gastroenterology (152 citations), Oncology (319 citations), Pathology and Forensic Medicine (183 citations), Dermatology (83 citations) and Pulmonary and Respiratory Medicine (153 citations). Frierson Hf has collaborated with scholars based in United States, Sweden and Belgium. Frequent co-authors include Gaffey Mj, Craig A. Rumpel, Q Tian, Douglas W. Franquemont, Christopher A. Moskaluk, Weiss Lm, Mills Se, Thomas Löning, Göran Stenman and Zarbo Rj. Their work appears in journals such as Oncogene, The Journal of Pathology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.